Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
3.220
+0.160 (5.23%)
At close: Oct 24, 2025, 4:00 PM EDT
3.290
+0.070 (2.17%)
After-hours: Oct 24, 2025, 6:28 PM EDT
Health Catalyst Market Cap
Health Catalyst has a market cap or net worth of $228.01 million as of October 24, 2025. Its market cap has decreased by -52.33% in one year.
Market Cap
228.01M
Enterprise Value
303.46M
1-Year Change
-52.33%
Ranking
Category
Stock Price
$3.22
Market Cap Chart
Since July 25, 2019, Health Catalyst's market cap has decreased from $1.37B to $228.01M, a decrease of -83.41%. That is a compound annual growth rate of -24.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 228.01M | -49.64% |
| Dec 31, 2024 | 452.79M | -15.04% |
| Dec 29, 2023 | 532.92M | -8.43% |
| Dec 30, 2022 | 582.00M | -71.78% |
| Dec 31, 2021 | 2.06B | 11.49% |
| Dec 31, 2020 | 1.85B | 45.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.08B |
| Johnson & Johnson | 462.74B |
| AbbVie | 403.22B |
| UnitedHealth Group | 326.45B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 236.86B |
| Abbott Laboratories | 219.89B |